Department of Oncology-Pathology
The Department of Oncology-Pathology conducts basic, translational and clinical research and educational activities related to cancer.
Frontiers in Cancer Research and Therapy
The annual international cancer conference is arranged on the 26th to 27th of March 2020 by the Department of Oncology-Pathology.
Several grants for OnkPat researchers from the Swedish Childhood Cancer Fund
The following OnkPat researchers have been granted funding from the Swedish Childhood Cancer Fund: Nina Gustafsson, Martin Enge, Janne Lehtiö, Georgios Rassidakis, Sean Rudd, Monika Ehnman, Felix Haglund, Joseph Carlson and Rozbeh Jafari.
Large grant for Johan Hartman
Large grant for Johan Hartman
Johan Hartman has together with Kevin Smith at the Royal Institute of Technology received a large grant of 20 million SEK from MedTechLabs to develop and implement AI-system for clinical breast cancer diagnostics.
Large research grant for Kenny Rodriguez-Wallberg
Large research grant for Kenny Rodriguez-Wallberg
Kenny Rodriguez-Wallberg at OnkPat has been granted large funding from The Swedish Cancer Society and The Swedish Research Council of a total of over 18 million SEK for her study on fertility preserving treatment of cancer patients.
A novel mechanism of immune escape
Shi Yong Neo and Andreas Lundqvist with colleagues at Karolinska Institutet have identified a novel mechanism how tumor cells can hijack the immune system to inhibit anti-tumor immune responses in breast cancer and sarcoma. The results have been published in The Journal of Clinical Investigation.
New principle for activation of cancer genes discovered
New principle for activation of cancer genes discovered
Researchers has long known that some genes can cause cancer when overactive, but exactly what happens inside the cell nucleus when the cancer grows has so far remained enigmatic. Now, Anita Göndör at OnkPat together with colleagues have found a new mechanism that renders one canonical driver of cancer overactive. The findings, published in Nature Genetics, create conditions for brand new strategies to fight cancer.
Fertility-sparing surgery is as good as radical surgery for early ovarian cancer
Young women with early stage ovarian cancer can undergo fertility-preserving surgery without affecting the safety of their cancer treatment, Gry Johansen and Kenny Rodriguez-Wallberg from OnkPat report in a national study published in the journal Gynecologic Oncology.
Smaller operational margins just as safe in high-risk melanoma
Hanna Eriksson and Deborah Utjés from OnkPat have in a multicenter study shown that it is enough with two centimeter margin at surgery for malignant melanoma instead of up to four centimeters which has been used. In the study, published in The Lancet, the researchers has followed over 900 patients for an average span of 19 years.